Training Example: DESCOVY (Gilead Sciences) – Review the Data, Give Your Score & Compare to the Real AI Evaluation

Industry Context — Common BS Fingerprints in Medical Devices, Pharma & Biotech
Generic Claims: advancing human health, breakthrough innovation, life-changing therapies, transforming patient outcomes…
Red Flags: FDA cleared used interchangeably with FDA approved, clinical claims without published study citations, breakthrough claims for incremental improvements, regulatory status implied but not specified…
Semantic Drift Patterns: homepage claims breakthrough but pipeline page shows preclinical only, FDA approved claims but only for one indication, marketed broadly, claims clinical evidence but links to poster presentations not published studies, claims global reach but regulatory approvals are single-market…
Proof Expectations: specific regulatory clearance numbers (FDA 510(k), CE, TGA), published clinical trial results with ClinicalTrials.gov registration, ISO 13485 and GMP certification details, peer-reviewed publication citations…

DESCOVY (Gilead Sciences)

(https://descovy.com) 📸 Data Snapshot: May 29, 2026

Analyze the raw signals below. How would a machine score this business’s credibility?

Here are the exact signals captured from up to six pages of the site — the same raw inputs the evaluation engine analyzed. They are grouped by signal type so you can weigh each the way the machine does.

🏗️ Semantic Structure — heading hierarchy & page identity (Info Density · Commodity Fingerprint)
HOMEPAGE DESCOVY for PrEP® (pre-exposure prophylaxis) (https://descovy.com)
Title

DESCOVY for PrEP® (pre-exposure prophylaxis)

Meta

Learn about DESCOVY® (emtricitabine and tenofovir alafenamide) for PrEP (pre-exposure prophylaxis). See Important Facts, including important warnings.

H2 99.7% of people stayed HIV-negative
H2 99.7% of people stayed HIV-negative
H2 99.7% of people stayed HIV-negative
H2 99.7% of people stayed HIV-negative
H2 99.7% of people stayed HIV-negative
H2 99.7% of people stayed HIV-negative
H2 99.7% of people stayed HIV-negative
H2 99.7% of people stayed HIV-negative
H2 99.7% of people stayed HIV-negative
H2 99.7% of people stayed HIV-negative
H2 99.7% of people stayed HIV-negative
H2 99.7% of people stayed HIV-negative
H2 99.7% of people stayed HIV-negative
H2 99.7% of people stayed HIV-negative
H5 DESCOVY is the smallest PrEP pill available and is one pill, once a day as part of your daily HIV prevention routine
H5 Sign up for emails and stay up to date on DESCOVY for PrEP
H6 while on DESCOVY for PrEP® in a 2-year study*
H6 while on DESCOVY for PrEP® in a 2-year study*
H6 while on DESCOVY for PrEP® in a 2-year study*
H6 while on DESCOVY for PrEP® in a 2-year study*
H6 while on DESCOVY for PrEP® in a 2-year study*
H6 while on DESCOVY for PrEP® in a 2-year study*
H6 while on DESCOVY for PrEP® in a 2-year study*
H6 while on DESCOVY for PrEP® in a 2-year study*
H6 while on DESCOVY for PrEP® in a 2-year study*
H6 while on DESCOVY for PrEP® in a 2-year study*
H6 while on DESCOVY for PrEP® in a 2-year study*
H6 while on DESCOVY for PrEP® in a 2-year study*
H6 while on DESCOVY for PrEP® in a 2-year study*
H6 while on DESCOVY for PrEP® in a 2-year study*
H6 Find a healthcare provider who prescribes PrEP.
H6 Pay as little as $0 per month. Restrictions apply.
H6 Hear experiences from DESCOVY users.
H6 DESCOVY is the smallest PrEP pill available and is one pill, once a day as part of your daily HIV prevention routine
H6 What is DESCOVY for PrEP?
H6 Important Safety Information
H6 You are leaving DESCOVY.COM
H6 You are leaving DESCOVY.COM
NAV_HEADER_HEADING_REPEATED Does DESCOVY for PrEP® Work? (https://descovy.com/about-descovy/clinical-trial-efficacy-results/)
Title

Does DESCOVY for PrEP® Work?

Meta

View the results of an HIV prevention trial that studied DESCOVY® (emtricitabine and tenofovir alafenamide) for PrEP (pre-exposure prophylaxis). See Important Facts, including important warnings.

H2 Study Results
H4 99.7% of people stayed HIV-negative while on DESCOVY for PrEP® in a 2-year study
H4 DESCOVY had less impact on bone health than TRUVADA
H4 DESCOVY had less impact on kidney function lab tests than TRUVADA
H5 Hear what real users think about the efficacy of DESCOVY.
H5 Discover more about DESCOVY for PrEP:
H6 The results were analyzed when everyone had been in the study for at least 2 years (~96 weeks), at that time:
H6 of people on DESCOVY stayed HIV-negative
H6 of people on TRUVADA®† stayed HIV-negative
H6 Hear what real users think about the efficacy of DESCOVY.
H6 For people taking DESCOVY in the DISCOVER trial, their BMD was less impacted than those taking TRUVADA (at about 2 years or ~96 weeks):
H6 Hear what inspires real users to share their experiences with DESCOVY for PrEP.
H6 Learn about the possible side effects of DESCOVY for PrEP.
H6 See how DESCOVY for PrEP could cost as little as $0. Restrictions apply.
H6 You are leaving DESCOVY.COM
H6 What is DESCOVY for PrEP?
H6 Important Safety Information
H6 You are leaving DESCOVY.COM
NAV_HEADER_HEADING_REPEATED DESCOVY for PrEP® (pre-exposure prophylaxis) Real Stories (https://descovy.com/real-stories/)
Title

DESCOVY for PrEP® (pre-exposure prophylaxis) Real Stories

Meta

View real stories of real people who have chosen DESCOVY® (emtricitabine and tenofovir alafenamide) as their PrEP medication. See Important Facts, including important warnings.

H2 Real Stories
H2 Real Stories
H4 Every DESCOVY user has a story
H5 DESCOVY Still Fits Their Lives
H6 DESCOVY Still Fits Their Lives
H6 Meet Philip AKA Peachez
H6 Meet Philip AKA Peachez
H6 Meet Veronica
H6 Meet Veronica
H6 Meet Dean
H6 Meet Dean
H6 Meet Everett Pt. 1
H6 Meet Everett Pt. 1
H6 Meet Everett Pt. 2
H6 Meet Everett Pt. 2
H6 Meet Kevin
H6 Meet Kevin
H6 Meet Kevin
H6 Meet Kyle
H6 Meet Kyle
H6 Meet Lamont
H6 Meet Lamont
H6 Meet Myka
H6 Meet Myka
H6 Meet Oli
H6 Meet Oli
H6 Meet Sergio
H6 Meet Sergio
H6 Meet Steve
H6 Meet Steve
H6 Meet Steve
H6 What is DESCOVY for PrEP?
H6 Important Safety Information
H6 You are leaving DESCOVY.COM
H6 You are leaving DESCOVY.COM
NAV_HEADER_HEADING_REPEATED DESCOVY for PrEP® Cost Support Information (https://descovy.com/descovy-for-prep-cost/)
Title

DESCOVY for PrEP® Cost Support Information

Meta

Learn how DESCOVY® (emtricitabine and tenofovir alafenamide) for PrEP (pre-exposure prophylaxis) could cost as little as $0. Restrictions apply. See Important Facts, including important warnings.

H2 Paying for DESCOVY for PrEP®
H5 DESCOVY for PrEP could cost as little as $0*
H5 Get started with the Gilead Advancing Access program
H5 Get financial and insurance help from Advancing Access
H6 You are leaving DESCOVY.COM
H6 If you have commercial insurance
H6 If you have government insurance
H6 If you do not have insurance
H6 “Not everybody has insurance, especially performers like me. I’m so grateful that there are programs like Advancing Access to help people afford PrEP medications."
H6 What is DESCOVY for PrEP?
H6 Important Safety Information
H6 You are leaving DESCOVY.COM
📝 The Narrative — clean text per page (Info Density · Semantic Coherence)
HOMEPAGE · THIN (https://descovy.com) DESCOVY for PrEP® (pre-exposure prophylaxis)

                            
0 chars
SUB-PAGE · THIN (https://descovy.com/about-descovy/clinical-trial-efficacy-results/) Does DESCOVY for PrEP® Work?

                            
0 chars
SUB-PAGE · THIN (https://descovy.com/real-stories/) DESCOVY for PrEP® (pre-exposure prophylaxis) Real Stories

                            
0 chars
SUB-PAGE · THIN (https://descovy.com/descovy-for-prep-cost/) DESCOVY for PrEP® Cost Support Information

                            
0 chars
🛡️ Trust Signals — reviews, proof links, trust-theatre flag (Trust & Proof)
1Review mentions (all pages)
0External proof links (all pages)
PageReviewsProof links
/ (home) 0 0
/about-descovy/clinical-trial-efficacy-results/ 0 0
/real-stories/ 1 0
/descovy-for-prep-cost/ 0 0
🔗 Identity & Technical Layer — schema JSON-LD: identity chains, entity gaps (Identity & Authority)
Homepage — no schema detected (entity gap)
/about-descovy/clinical-trial-efficacy-results/ — no schema detected (entity gap)
/real-stories/ — no schema detected (entity gap)
/descovy-for-prep-cost/ — no schema detected (entity gap)

Your Diagnosis

Before revealing the machine’s verdict, predict the BS score for each signal. Higher = more BS (more fluff, less verifiable substance). Drag each slider, then submit to compare your judgment against the engine.

Information Density 0 / 30
Read the Narrative & headings: do hard facts (prices, dates, numbers) outweigh fluff power-words?
Semantic Coherence 0 / 20
Compare the homepage promise against the sub-page reality. Do they hold the same line?
Trust & Proof 0 / 20
Weigh review mentions against actual external proof links. Claims without verification = theatre.
Commodity Fingerprint 0 / 15
Check headings & narrative against the industry clichés in the setup above.
Identity & Authority 0 / 15
Inspect the schema: is there real Organization/Person identity with sameAs links, or gaps?
Your predicted BS score 0 / 100
💡 Stuck? Reveal the heuristic lens — how the deterministic page-auditor reads each signal (no AI, pure pattern rules)

These are the structural rules a local, deterministic auditor applies — the same lens you can use to judge each signal. They describe what to look for, not this company’s result.

Information Density

Classify each sentence as substantive or hollow. Grounding markers — numbers, currencies, dates, technical units, named entities — outweigh marketing adjectives. When fluff sits right next to hard evidence, the fluff is forgiven.

Semantic Alignment

Pull the main entities out of the H1, then check whether they actually recur through the body. A page that announces one thing and then talks about another drifts. Headings with no real sentences underneath read as pseudo-substance.

Trust & Proof

Count trust words (review, testimonial, rating, verified) against real outbound proof links (Google, Trustpilot, Clutch, G2, Yelp). Lots of trust language with zero verification links is trust theatre. Unlinked logo galleries count against it.

Commodity Fingerprint

Look at how much sentence length varies. Natural writing varies its rhythm; templated or mass-produced copy is statistically uniform. Very low variation reads as commodity content — unless unique named entities break the pattern.

Identity & Authority

Inspect the JSON-LD. Is there an Organization or Person schema, and does it carry sameAs links to real external profiles (LinkedIn, socials)? Missing schema or no identity declaration signals an anonymous entity.

Want to apply this lens yourself? The free BS Indicator Chrome extension runs these heuristic checks live on any page. Bear in mind it is a single-page, deterministic tool — it relies only on pattern rules for the page in front of it and does not perform the cross-page semantic correlation this audit uses, so its readout is a starting lens, not the full verdict.

B
BS Level
Medical Devices, Pharma & Biotech
40.7 Avg BS

Based on 784 businesses audited.

BS Detector

Medical Devices, Pharma & Biotech BS: DESCOVY (Gilead Sciences) (descovy.com)

https://descovy.com 📍 Industry: Medical Devices, Pharma & Biotech
35 BS / 100

DESCOVY.COM is a high-substance pharmaceutical site that uses high-frequency repetition to drive home a singular clinical success metric. It successfully avoids the ‘hot air’ trap by tethering every major marketing claim to specific DISCOVER trial data, though it fails technical authority checks due to an absolute lack of structured data.

Info Density Power-words vs. Substance ratio.
9
30% BS
Semantic Coherence Homepage promise vs. Sub-page reality.
2
10% BS
Trust & Proof Verifiable evidence vs. Trust Theatre.
10
50% BS
Commodity Fingerprint Detection of industry clichés/templates.
4
27% BS
Identity & Authority Expert verifiability & Schema depth.
10
67% BS

Eliminate the 14x repetition of the 99.7% H2 on the homepage to improve the heading hierarchy and user experience. Implement Product and Organization schema (JSON-LD) to link claims directly to clinical trial registry entries and Gilead’s corporate entity. Replace anecdotal ‘Real Stories’ headers with more descriptive context about the participant’s trial involvement. Provide direct outbound links to peer-reviewed publications of the DISCOVER trial results in the footer or clinical results page.

The content perfectly aligns with the Pharma & Biotech industry, specifically the therapeutic area of HIV prevention (PrEP). All technical terminology such as ’emtricitabine and tenofovir alafenamide,’ ‘BMD,’ and ‘kidney function lab tests’ is industry-appropriate.

“The BS score of 35 is primarily driven by Identity and Authority gaps (missing schema) and Trust Theatre (unverified reviews). The score is kept low by high Information Density and excellent Semantic Coherence, as the site provides hard clinical evidence for its primary marketing signals.”

Verified Analysis Date: May 29, 2026 © 1EuroSEO Independent Evaluator — Non-Sponsored Result
Brand AI Reputation